453.78MGBP
Type
Common Stock
Exchange
LSE
Currency Code
GBX
Currency Name
Pence sterling
Country Name
UK
Country ISO
GB
ISIN
GB00BDFBVT43
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.54
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.42
Wall Street Target Price
512.29
EPS Estimate Current Year
-0.28
EPS Estimate Next Year
-0.04
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
128,797,000
Gross Profit TTM
53,021,000
EBITDA
-20,887,000
Profit Margin
-33.53%
Return On Assets TTM
-9.76%
Return On Equity TTM
-70.28%
Revenue Per Share TTM
1.245
Qtly Revenue Growth YOY
67.80%
Diluted Eps TTM
-0.42
Qtly Earnings Growth YOY
106.90%
Trailing PE
0.00
Forward PE
250
Price Sales TTM
2.5659
Price Book MRQ
5.7095
Enterprise Value Revenue
2
Enterprise Value EBITDA
-819
202.50
6.58%136.90
0.96%107.50
0.83%1.71
0.36%1315.50
0.04%985.00
0.00%2750.00
0.00%2045.00
0.00%0.91
-2.39%124.60
-1.42%